Patients on popular diabetes and weight loss jabs must be warned about their increased risk of a serious airway complication ...

Biocon has received approval in India for its generic version of Victoza, marking its first GLP-1 diabetes therapy clearance ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight ...

Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns ...

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

Overall, the study found, ceasing weight loss drugs is likely to yield a more rapid weight regain than ... concerning Byetta and seven concerning Victoza ("older" medications, approved in 2005 ...

Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older ...

Novo Nordisk NVO shares have gained 13.9% in the past month. Several factors related to the company’s pipeline, regulatory updates and sector-specific developments have contributed to the much-awaited ...

Moreover, rapid weight loss activates the hypothalamic-pituitary-adrenal axis, promoting continuous cortisol release, which is associated with a higher risk for depression and suicide. As ...

Leading dentist Dr Sofina Ahmed shares how GLP-1 medications are creating visible and lasting changes to smiles ...